Stay Updated
For all press requests, please reach out to press@p4adnow.org.
News and Reports
Bloomberg Law: Boehringer Fails to Revive Suit Over US Drug Price Talks
The ruling is “another clear win for patients,” Merith Basey, executive director of Patients for Affordable Drugs, said in a statement. “Medicare negotiation is set to deliver lower prices to more than 9 million patients across the nation in less than six months, and the popular program is standing strong against the industry’s legal attacks,” […]
News and Reports
Fierce Healthcare: Drug price negotiation program sidesteps latest legal obstacle
“This decision marks the 10th court ruling in favor of patients and against the pharmaceutical industry’s desperate legal attacks on the overwhelmingly popular Medicare negotiation program, which in January will deliver lower prices to more than 9 million patients across the nation,” said Merith Basey, executive director for advocacy group Patients for Affordable Drugs, in […]
News and Reports
IP Watchdog: Appellate Challenges to Medicare Drug Price Negotiation Program Fail
…Patient advocacy group Patients for Affordable Drugs (P4AD), meanwhile, cheered the two decisions, calling the Second Circuit ruling “a decisive win for patients.” And P4AD Executive Director Merith Basey touted the Sixth Circuit’s decision as “the 10th court ruling in favor of patients and against the pharmaceutical industry’s desperate legal attacks on the overwhelmingly popular […]
News and Reports
Healthcare Finance: Appeals court upholds Drug Price Negotiation Program
Patients For Affordable Drugs (P4AD) said it submitted four amicus briefs on behalf of patients and signed onto seven briefs supported by Protect Our Care, Doctors for America, and Families USA to support the government’s opposition to the lawsuits. P4AD Executive Director Merith Basey said, “This decision marks the 10th court ruling in favor of […]
News and Reports
Bloomberg Law: Court Again Rejects PhRMA Suit Against US Drug Price Talks
The third ruling is another “win for patients nationwide,” Merith Basey, executive director of Patients for Affordable Drugs, said in a statement. “Pharma has been dealt three decisive blows in the last 48 hours,” Basey said. “These rulings represent a strong judicial affirmation that the Medicare Drug Price Negotiation Program is here to stay and […]
News and Reports
The Hill: 2 more cases challenging Medicare negotiation rejected in federal courts
Merith Basey, executive director of the advocacy group Patients For Affordable Drugs, lauded the rulings in a statement Thursday. “Once again, a drug company brought its high-priced lawyers to lay out its arguments against Medicare negotiation, and once again they have lost. This ruling against Boehringer Ingelheim marks the fifth consecutive legal victory for patients […]
News and Reports
POLITICO Pro Health Care PM: Pharma Defeated, Again
Advocacy organizations dedicated to lowering prescription drug prices have jumped to hail the back-to-back rulings as a patient victory. “The ruling affirms what we’ve known all along: Big Pharma’s legal arguments are baseless, and their scare tactics are failing,” Merith Basey, executive director of Patients for Affordable Drugs Now, said in a statement today. “Medicare […]
News and Reports
Inside Drug Pricing: IRA Suits Dismissed Back-To-Back By Two Appeals Courts
Patients for Affordable Drugs and other advocates for federal drug pricing reform are pleased with the back-to-back appellate decisions. The BI ruling further emphasizes that pharmaceutical companies cannot claim constitutional violations because they are opposed to the terms of doing business with the government, the advocates said. “It’s the U.S. versus Pharma, and today’s decision […]